NLM Digital Collections

Search

Start Over Subjects Drug and Narcotic Control ✖Remove constraint Subjects: Drug and Narcotic Control

1. Prescription drugs: impacts of misuse and accidental overdose in Mississippi

Publication:
Jackson, Mississippi, : Center for Mississippi Health Policy, September 2013
Subject(s):
Drug Overdose -- epidemiology
Drug Overdose -- prevention & control
Prescription Drug Misuse -- mortality
Prescription Drug Misuse -- prevention & control
Prescription Drug Monitoring Programs -- legislation & jurisprudence
Drug and Narcotic Control
Prescription Drug Misuse -- economics
Prescription Drugs -- poisoning
Humans
Mississippi
United States

2. Drugs resources: manufacturers, importers, processors : biologicals, botanicals, containers, fish liver oils, narcotics, hormones and glandular substances, medicinal chemicals, surgical dressings

Author(s):
Morgan, Clifford V., author
Baumann, Chas. A., author
Publication:
Washington, D.C. : War Department, Office of the Under Secretary of War, October 1941
Subject(s):
Drug Industry
Pharmaceutical Preparations
Drug and Narcotic Control
United States

4. Prescription drug monitoring programs: evolution and evidence

Author(s):
Weiner, Janet, author
Bao, Yuhua, author
Meisel, Zachary, author
Publication:
Philadelphia, PA : Leonard Davis Institute of Health Economics, June 2017
Subject(s):
Analgesics, Opioid -- adverse effects
Analgesics, Opioid -- therapeutic use
Drug and Narcotic Control
Drug Overdose -- epidemiology
Government Programs
Inappropriate Prescribing -- prevention & control
Opioid-Related Disorders
Mandatory Programs
State Government
Humans
United States

17. Memory supplements: clarifying FDA and FTC roles could strengthen oversight and enhance consumer awareness : report to Congressional requesters

Publication:
Washington, D.C. : U.S. Government Accountability Office, May 2017
Subject(s):
Dietary Supplements
Drug and Narcotic Control
Government Regulation
Marketing of Health Services
Memory -- drug effects
Memory Disorders -- drug therapy
Advertising as Topic
Commerce
Internet
Humans
United States
United States. Federal Trade Commission.
United States. Food and Drug Administration.

18. Report of the Committee on Adulterations and Sophistications of Drugs, Medicines, Chemicals, etc: presented to the American Medical Association at its third annual meeting, held in Cincinnati, May, 1850

Author(s):
American Medical Association. Committee on Adulterations and Sophistications of Drugs, Medicines, Chemicals, etc.
Publication:
Philadelphia : T.K. & P.G. Collins, printers to the Association, 1850
Subject(s):
Drug Contamination
Drug and Narcotic Control
United States

20. Preventing drug abuse: low participation by pharmacies and other entities as voluntary collectors of unused prescription drugs : report to Congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, October 2017
Subject(s):
Drug and Narcotic Control
Prescription Drug Diversion -- prevention & control
Prescription Drug Misuse -- prevention & control
Voluntary Programs
Government Programs
Pharmacies
Prescription Drugs
State Government
Humans
United States
United States. Drug Enforcement Administration.

21. Prescription opioids: Medicare should expand oversight efforts to reduce the risk of harm : testimony before the Subcommittee on Oversight, Committee on Ways and Means, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, January 17, 2018
Subject(s):
Drug and Narcotic Control
Inappropriate Prescribing -- prevention & control
Medicare Part D -- statistics & numerical data
Opioid-Related Disorders
Prescription Drug Misuse -- statistics & numerical data
Analgesics, Opioid -- adverse effects
Fraud -- prevention & control
Government Regulation
Inappropriate Prescribing -- statistics & numerical data
Medicare Part D -- economics
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)

23. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, October 2020
Subject(s):
Drug Industry
Drug and Narcotic Control
Pharmaceutical Preparations
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.

25. E2B(R3) electronic transmission of Individual Case Safety Reports (ICSRs) implementation guide: data elements and message specification

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, April 2022
Subject(s):
Adverse Drug Reaction Reporting Systems
Drug and Narcotic Control
Electronic Mail
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

26. Pain in the nation: the drug, alcohol and suicide crises and the need for a national resilience strategy

Author(s):
Segal, Laura M., author
De Biasi, Anne, author
Mueller, Jennifer May, author
May, Kendra, author
Warren, Molly, author
Publication:
Washington, DC : Trust for America's Health, November 2017
Subject(s):
Alcohol-Related Disorders -- epidemiology
Resilience, Psychological
Substance-Related Disorders -- epidemiology
Suicide -- statistics & numerical data
Adolescent
Adult
Alcohol-Related Disorders -- economics
Alcohol-Related Disorders -- mortality
Alcohol-Related Disorders -- prevention & control
Child
Child Abuse
Child Health Services
Child Welfare
Community Mental Health Services
Continental Population Groups
Cost of Illness
Drug and Narcotic Control
Education, Nonprofessional
Family
Food Assistance
Forecasting
Health Care Costs -- statistics & numerical data
Housing
Illicit Drugs
Infant
Life Expectancy
Mental Disorders
Mental Health Services
Middle Aged
Mortality -- trends
Opioid-Related Disorders -- epidemiology
Opioid-Related Disorders -- mortality
Opioid-Related Disorders -- prevention & control
Pain Management
Parenting
Patient Care Team
Practice Patterns, Physicians'
Pregnancy
Prisoners
Rural Population
School Health Services
State Government
Substance-Related Disorders -- economics
Substance-Related Disorders -- mortality
Substance-Related Disorders -- prevention & control
Suicide -- prevention & control
Urban Population
Humans
United States

29. Buprenorphine: an overview for clinicians

Author(s):
Steiger, Scott, author
DeFries, Triveni, author
Publication:
[Oakland, California] : California Health Care Foundation, August 2019
Subject(s):
Buprenorphine -- therapeutic use
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Ambulatory Care
Buprenorphine -- administration & dosage
Buprenorphine -- adverse effects
Drug and Narcotic Control
Emergency Service, Hospital
Health Services Accessibility
Mental Health Services
Methadone -- therapeutic use
Naltrexone -- therapeutic use
Pain -- drug therapy
Prescription Drug Diversion
Prisons
State Government
Telemedicine
Humans
California
United States

32. Considerations for the use of real-world data and real-world evidence to support regulatory decision-making for drug and biological products: guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Biological Products
Clinical Trials as Topic
Data Analysis
Decision Making
Drug Approval
Drug Industry
Drug and Narcotic Control
Government Regulation
United States
United States.

33. Wholesale distributor verification requirement for saleable returned drug product and dispenser verification requirements when investigating a suspect or illegitimate product: compliance policies : guidance for industry

Publication:
Silver Spring, MD : Center for Drug Evaluation and Research, August 2023
Subject(s):
Counterfeit Drugs
Drug Industry
Drug and Narcotic Control
Fraud
Government Regulation
Substandard Drugs
United States
United States.

35. The traffic in habit-forming narcotic drugs: hearings before the Committee on Foreign Affairs, House of Representatives, Sixty-eighth Congress, first session on H. J. Res. 195 authorizing an appropriation for the participation of the United States in the two international conferences for the control of the traffic in habit-forming narcotic drugs : February 21, 1924 : Statement of the attitude of the government of the United States with documents relating thereto = Le trafic des drogues narcotiques : séances du Comité des Affaires etrangères, Chambre des Représentants, soixante huitiéme congrès, première session, resolution de la Chambre no. 195 accordant un crédit pour la participation des Etats-Unis aux deux conférences internationales du contrôle de l'opium : 21 février 1924 : Déclaration sur l'attitude du Gouvernment des Etats-Unis augmentée des documents s'y référant

Author(s):
Erk, Edmund Frederick, 1872-1953 compiler
Publication:
Washington : Government Printing Office, 1924
Subject(s):
Budgets -- legislation & jurisprudence
Drug and Narcotic Control
Legislation, Drug
Opium
Substance-Related Disorders
United States